Skip to main content
. 2021 Mar;9(6):493. doi: 10.21037/atm-21-1134

Figure 3.

Figure 3

Survival curves for all 42 patients with neoadjuvant therapy. (A) Relapse-free survival grouped by MPR or non-MPR. (B) Overall survival grouped by MPR or non-MPR. (C) Relapse-free survival grouped by high-risk subtype or others. (D) Overall survival grouped by high-risk subtype or others. MPR, major pathologic response.